Intervention
FOLFOX
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 3 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
3 shownA Study of PHST001 in Advanced Solid TumorsNCT06840886 · 2025-03-31
RECRUITINGOpen-Label Study of BBO-10203 in Subjects With Advanced Solid TumorsNCT06625775 · 2024-10-29
RECRUITINGA Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D MutationNCT06179160 · 2024-01-04
RECRUITINGCommon conditions
Advanced Breast Cancer1Advanced Lung Cancer1Advanced Solid Tumors1Breast Cancer1Carcinosarcoma, Ovarian1Cholangiocarcinoma1CNS Tumor1Endometrial Cancer1Fallopian Tube Cancer1HER2 Mutation-Related Tumors1HER2-positive Advanced Breast Cancer1HER2-positive Metastatic Breast Cancer1HR-positive, HER2-negative Advanced Breast Cancer1KRAS Mutant Metastatic Colorectal Cancer1Metastatic Breast Cancer1Metastatic Colorectal Cancer1Metastatic Lung Cancer1Ovarian Cancer1Primary Peritoneal Carcinoma1Solid Tumor, Adult1Solid Tumors1
Leading sponsors
Trial status mix
RECRUITING3
Phase mix
PHASE13
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.